78 related articles for article (PubMed ID: 1959621)
1. Fibronectin is a non-viral substrate for the HIV proteinase.
Oswald M; von der Helm K
FEBS Lett; 1991 Nov; 292(1-2):298-300. PubMed ID: 1959621
[TBL] [Abstract][Full Text] [Related]
2. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.
Konvalinka J; Litterst MA; Welker R; Kottler H; Rippmann F; Heuser AM; Kräusslich HG
J Virol; 1995 Nov; 69(11):7180-6. PubMed ID: 7474139
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic activity in vivo and encapsidation of recombinant human immunodeficiency virus type 1 proteinase expressed in baculovirus-infected cells.
Royer M; Bardy M; Gay B; Tournier J; Boulanger P
J Gen Virol; 1997 Jan; 78 ( Pt 1)():131-42. PubMed ID: 9010296
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of a native substrate of the HIV-1 proteinase.
Partin K; Wimmer E; Carter C
Adv Exp Med Biol; 1991; 306():503-6. PubMed ID: 1667451
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 proteinase is required for synthesis of pro-viral DNA.
Baboonian C; Dalgleish A; Bountiff L; Gross J; Oroszlan S; Rickett G; Smith-Burchnell C; Troke P; Merson J
Biochem Biophys Res Commun; 1991 Aug; 179(1):17-24. PubMed ID: 1652947
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
Paulus C; Ludwig C; Wagner R
Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
Tözsér J; Bláha I; Copeland TD; Wondrak EM; Oroszlan S
FEBS Lett; 1991 Apr; 281(1-2):77-80. PubMed ID: 2015912
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
Yu FH; Wang CT
Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
[TBL] [Abstract][Full Text] [Related]
9. Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease.
Wondrak EM; Louis JM
Biochemistry; 1996 Oct; 35(39):12957-62. PubMed ID: 8841142
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
11. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
12. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
[TBL] [Abstract][Full Text] [Related]
13. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of active form of HIV-1 protease from E.coli.
Wan M; Loh BN
Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
[TBL] [Abstract][Full Text] [Related]
15. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
16. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
[TBL] [Abstract][Full Text] [Related]
17. Regulation of intracellular human immunodeficiency virus type-1 protease activity.
Gatlin J; Arrigo SJ; Schmidt MG
Virology; 1998 Apr; 244(1):87-96. PubMed ID: 9581782
[TBL] [Abstract][Full Text] [Related]
18. Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus.
Sedlacek J; Fabry M; Coward JE; Horejsi M; Strop P; Luftig RB
Virology; 1993 Feb; 192(2):667-72. PubMed ID: 7678476
[TBL] [Abstract][Full Text] [Related]
19. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
[TBL] [Abstract][Full Text] [Related]
20. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
